G R O U P 3

NSO:
INCENTIVE
SPIROMETRY AND
MANTOUX TEST
MEMBERS:

BANTILLO, ROSE CAMILLE LUMONTAD, ARIENE MAY

GO, MICHAELA SALAZAR, KRYSTAL MAE
JALANI, SHERMINA VESAGAS, KRISTELLE
 INCENTIVE SPIROMETRY
Incentive spirometry is a method of deep breathing that provides visual feedback to encourage the patient to inhale
slowly and deeply and achieve maximum lung inflation. The goal is to ensure that the volume of air inhaled is increased
gradually as the patient takes deeper and deeper breaths.

BEFORE DURING AFTER

1. Instruct the patient to breathe out into the room with a
1. Verify physician's order complete exhalation. 1. Auscultate the patient's
and identify patient using 2. Place mouthpiece in mouth, between teeth, and seal lips chest to evaluate
two identifiers. around mouthpiece. effectiveness of therapy.
2. Wash hands. 3. Instruct the patient to inhale as deeply and slowly as 2. Explain to the patient that
3. Assemble Incentive possible from the mouthpiece and to continue to hold for the exercise may be
Spirometer Unit three (3) seconds. repeated every hour on its
4. Explain therapy. 4. Instruct the patient to relax, remove the mouthpiece and let own.
5. Explain procedure. air out into the room. 3. Document the response of
6. Position patient, as 5. Repeat exercise as tolerated by the patient. the patient to the
allowed by condition 6. Instruct patient to remove mouthpiece from mouth after procedure.
7. Auscultate chest. each deep inhaltion and post-inspiratory hold.

Breathing control is provided by the indication. You're breathing in too quickly if the indicator moves over the higher
arrow. You're inhaling too slowly if the signal remains below the bottom arrow. The indicator should be kept in between
the two arrows (in line with 1,500 cc). This implies that your breathing is even and under control.
 MANTOUX TEST
Mantoux test is used for detecting tuberculosis infection. It is used to determine whether a person has been infected with
the TB bacillus and is used in screening for latent M. tuberculosis infection.

BEFORE DURING AFTER

1. Discuss purpose of skin 1. Stretch the skin, hold a syringe parallel, insert a needle,
test, what is involve, and bevel up, release skin, and inject 0.1mL of tuberculin. 1. Educate Patients. The
when the patient should 2. A pale wheal 6-10 mm in diameter should appear patient must return 48-72
return. immediately after an injection. If fluid leaks or no wheal, hours after the test is
2. Let the patient sit, rest the administer a second injection. administered to measure
arm comfortably and 3. The test is conducted 48-72 hours after administration, and evaluate their
clean the injection site check for induration by inspecting the arm against light and induration. If they cannot
with an alcohol pad palpating the arm gently. return within this time, the
3. Avoid injecting air into 4. Measure induration's transverse diameter to the forearm's test should not be
vials during dose drawing. long axis, often difficult to palpate. Use a 45° angle ballpoint administered, but a new
Draw over 0.1 ml, remove pen to stop at the induration's edge. appointment should be
air, expel one drop, and 5. Measure induration between pen points using a caliper or scheduled.
ensure full 0.1 ml remains ruler, record in millimeters, and provide a record to the client
in the syringe. if the measurement falls between demarcations.
1. Positive Mantoux Test: 2. Negative Mantoux Test: 3. Intermediate Test:
Indicators of a positive response include 5 The absence of significant induration at the Due to a variety of factors, such as problems
mm, 10 mm, and 15 mm of induration, injection site is indicated by a negative result. with the injection technique or
depending on the population and the person's immunosuppression, the test results may at
risk factors. times be unreliable.